Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV

Microstructural brain abnormalities in HIV+ individuals with or without chronic marijuana use

(2020) Hannah A. Wang et al.   Journal of Neuroinflammation

Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood

(2020) Ronald J. Ellis et al.   Neurology-Neuroimmunology & Neuroinflammation

Evidence-informed practical recommendations for increasing physical activity among persons living with HIV

(2019) Jessica L. Montoya et al.   AIDS

Distinct inflammatory profiles in HIV-infected individuals under ART using cannabis, cocaine or cannabis plus cocaine

(2019) Fernanda de Oliveira Feitosa de Castro et al.   AIDS

Plasma CXCL10 correlates with HAND in HIV-infected women

(2019) R. Burlacu et al.   JOURNAL OF NEUROVIROLOGY

Δ9-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7–Stimulated Human Coculture

(2019) Michael D. Rizzo et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Sex Differences in Neurocognitive Function in Adults with HIV: Patterns, Predictors, and Mechanisms

(2019) Leah H. Rubin et al.   Current Psychiatry Reports

Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV

(2019) Caitlin Wei-Ming Watson et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy–Treated Human Immunodeficiency Virus–Infected Individuals

(2018) Jennifer A Manuzak et al.   CLINICAL INFECTIOUS DISEASES

The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment

(2018) Staci A. Gruber et al.   Frontiers in Pharmacology

Effects of trauma, economic hardship, and stress on neurocognition and everyday function in HIV.

(2018) Caitlin Wei-Ming Watson et al.   HEALTH PSYCHOLOGY

The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity

(2018) Dicky Struik et al.   Frontiers in Behavioral Neuroscience

Does Cannabis Use Cause Declines in Neuropsychological Functioning? A Review of Longitudinal Studies

(2017) Raul Gonzalez et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

HIV-Associated Neurocognitive Disorders: A Global Perspective

(2017) Rowan Saloner et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice

(2017) Andras Bilkei-Gorzo et al.   NATURE MEDICINE

Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression

(2016) Brandon M. Imp et al.   JOURNAL OF INFECTIOUS DISEASES

HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

(2016) Deanna Saylor et al.   Nature Reviews Neurology

Neuroinflammation in treated HIV-positive individuals

(2016) Jaime H. Vera et al.   NEUROLOGY

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

(2015) Nikolas Itaru Wada et al.   AIDS

Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications

(2015) Suzi Hong et al.   BRAIN BEHAVIOR AND IMMUNITY

Cannabinoids for Medical Use

(2015) Penny F. Whiting et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium

(2015) Yuri Persidsky et al.   Journal of Neuroimmune Pharmacology

Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells

(2015) Lei Yang et al.   MEDIATORS OF INFLAMMATION

The Relationship of CSF and Plasma Cytokine Levels in HIV Infected Patients with Neurocognitive Impairment

(2015) Lin Yuan et al.   Biomed Research International

HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways

(2013) Rachel P. Simmons et al.   AIDS

Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection

(2013) Tricia H. Burdo et al.   AIDS

Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists

(2013) Servio H. Ramirez et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation

(2013) Slava Rom et al.   Journal of Neuroimmune Pharmacology

Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China

(2013) Lin Yuan et al.   JOURNAL OF NEUROVIROLOGY

Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain

(2013) Geeta Ramesh et al.   MEDIATORS OF INFLAMMATION

Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection

(2012) Anupa Kamat et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator

(2012) Rajeev Mehla et al.   Journal of Neuroinflammation

CB1 and CB2 Receptor Expression and Promoter Methylation in Patients with Cannabis Dependence

(2012) Andrea Rotter et al.   EUROPEAN ADDICTION RESEARCH

A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations

(2011) Lynn Pulliam et al.   AIDS

Current understanding of HIV-associated neurocognitive disorders pathogenesis

(2011) Patrick Gannon et al.   CURRENT OPINION IN NEUROLOGY

Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test–Revised, Brief Visuospatial Memory Test–Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version

(2011) Marc A. Norman et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

CCL2/MCP-1 modulation of microglial activation and proliferation

(2011) Ara E Hinojosa et al.   Journal of Neuroinflammation

Activation of Cannabinoid Type 2 Receptors Inhibits HIV-1 Envelope Glycoprotein gp120-Induced Synapse Loss

(2011) H. J. Kim et al.   MOLECULAR PHARMACOLOGY

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

(2011) J Hirvonen et al.   MOLECULAR PSYCHIATRY

Neuronal MCP-1 Mediates Microglia Recruitment and Neurodegeneration Induced by the Mild Impairment of Oxidative Metabolism

(2010) Guang Yang et al.   BRAIN PATHOLOGY

Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

(2010) Jacqueline Neuhaus et al.   JOURNAL OF INFECTIOUS DISEASES

Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning

(2010) Ronald A. Cohen et al.   JOURNAL OF NEUROIMMUNOLOGY

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

(2010) Robert K. Heaton et al.   JOURNAL OF NEUROVIROLOGY

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY

Cannabinoids as novel anti-inflammatory drugs

(2009) Prakash Nagarkatti et al.   Future Medicinal Chemistry

Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial

(2008) Ronald J Ellis et al.   NEUROPSYCHOPHARMACOLOGY